Cargando…

Intranasal vaccination induced cross-protective secretory IgA antibodies against SARS-CoV-2 variants with reducing the potential risk of lung eosinophilic immunopathology

To control the coronavirus disease 2019 (COVID-19) pandemic, there is a need to develop vaccines to prevent infection with severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) variants. One candidate is a nasal vaccine capable of inducing secretory IgA antibodies in the mucosa of the upper r...

Descripción completa

Detalles Bibliográficos
Autores principales:	Hemmi, Takuya, Ainai, Akira, Hashiguchi, Takao, Tobiume, Minoru, Kanno, Takayuki, Iwata-Yoshikawa, Naoko, Iida, Shun, Sato, Yuko, Miyamoto, Sho, Ueno, Akira, Sano, Kaori, Saito, Shinji, Shiwa-Sudo, Nozomi, Nagata, Noriyo, Tamura, Koji, Suzuki, Ryosuke, Hasegawa, Hideki, Suzuki, Tadaki
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Elsevier Ltd. 2022
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9439873/ https://www.ncbi.nlm.nih.gov/pubmed/36064667 http://dx.doi.org/10.1016/j.vaccine.2022.08.049

Ejemplares similares

A lethal mouse model for evaluating vaccine-associated enhanced respiratory disease during SARS-CoV-2 infection
por: Iwata-Yoshikawa, Naoko, et al.
Publicado: (2022)

Results from a preclinical study in rodents and a Phase 1/2, randomized, double-blind, placebo-controlled, parallel-group study of COVID-19 vaccine S-268019-a in Japanese adults
por: Sonoyama, Takuhiro, et al.
Publicado: (2023)

High-throughput isolation of SARS-CoV-2 nucleocapsid antibodies for improved antigen detection
por: Fujisawa, Mizuki, et al.
Publicado: (2023)

Saturation time of exposure interval for cross-neutralization response to SARS-CoV-2: Implications for vaccine dose interval
por: Miyamoto, Sho, et al.
Publicado: (2023)

Immune response and protective efficacy of the SARS-CoV-2 recombinant spike protein vaccine S-268019-b in mice
por: Homma, Tomoyuki, et al.
Publicado: (2022)

cGAMP Promotes Germinal Center Formation and Production of IgA in Nasal-Associated Lymphoid Tissue
por: Takaki, Hiromi, et al.
Publicado: (2017)

Structure-Guided Creation of an Anti-HA Stalk Antibody F11 Derivative That Neutralizes Both F11-Sensitive and -Resistant Influenza A(H1N1)pdm09 Viruses
por: Kotani, Osamu, et al.
Publicado: (2021)

Impacts of allergic airway inflammation on lung pathology in a mouse model of influenza A virus infection
por: Kawaguchi, Akira, et al.
Publicado: (2017)

Vaccination-infection interval determines cross-neutralization potency to SARS-CoV-2 Omicron after breakthrough infection by other variants
por: Miyamoto, Sho, et al.
Publicado: (2022)

Intranasal vaccination with an inactivated whole influenza virus vaccine induces strong antibody responses in serum and nasal mucus of healthy adults
por: Ainai, Akira, et al.
Publicado: (2013)

Essential role of TMPRSS2 in SARS-CoV-2 infection in murine airways
por: Iwata-Yoshikawa, Naoko, et al.
Publicado: (2022)

Shape-dependent adjuvanticity of nanoparticle-conjugated RNA adjuvants for intranasal inactivated influenza vaccines
por: Tazaki, Taiyu, et al.
Publicado: (2018)

Impact of Reinfection with SARS-CoV-2 Omicron Variants in Previously Infected Hamsters
por: Shiwa-Sudo, Nozomi, et al.
Publicado: (2023)

TMPRSS2 Contributes to Virus Spread and Immunopathology in the Airways of Murine Models after Coronavirus Infection
por: Iwata-Yoshikawa, Naoko, et al.
Publicado: (2019)

Neutralizing-antibody-independent SARS-CoV-2 control correlated with intranasal-vaccine-induced CD8(+) T cell responses
por: Ishii, Hiroshi, et al.
Publicado: (2022)

Non-Omicron breakthrough infection with higher viral load and longer vaccination-infection interval improves SARS-CoV-2 BA.4/5 neutralization
por: Miyamoto, Sho, et al.
Publicado: (2023)

Immunogenicity and protective efficacy of SARS-CoV-2 recombinant S-protein vaccine S-268019-b in cynomolgus monkeys
por: Hashimoto, Masayuki, et al.
Publicado: (2022)

Human immune responses elicited by an intranasal inactivated H5 influenza vaccine
por: Ainai, Akira, et al.
Publicado: (2020)

2141. Preclinical Evaluation of PA-001: A Novel, Potential Macrocyclic Peptide-Based Treatment for COVID-19 Which Binds to the S2 Subunit of SARS-CoV-2 Spike Protein
por: Kawamura, Tatsuro, et al.
Publicado: (2023)

An influenza HA stalk reactive polymeric IgA antibody exhibits anti-viral function regulated by binary interaction between HA and the antibody
por: Sano, Kaori, et al.
Publicado: (2021)

Effectiveness of personal protective equipment in preventing severe acute respiratory syndrome coronavirus 2 infection among healthcare workers()
por: Suzuki, Tetsuya, et al.
Publicado: (2021)

Isolation of human monoclonal antibodies with neutralizing activity to a broad spectrum of SARS-CoV-2 viruses including the Omicron variants
por: Ueno, Mikako, et al.
Publicado: (2022)

IgA tetramerization improves target breadth but not peak potency of functionality of anti-influenza virus broadly neutralizing antibody
por: Saito, Shinji, et al.
Publicado: (2019)

Maternal intranasal immunization with HTLV-1 Env induces Env specific antibody responses in breast milk
por: Suzuki, Tadaki
Publicado: (2015)

Development of mucosal adjuvants for intranasal vaccine for H5N1 influenza viruses
por: Hasegawa, Hideki, et al.
Publicado: (2009)

Duration of Infectious Virus Shedding by SARS-CoV-2 Omicron Variant–Infected Vaccinees
por: Takahashi, Kenichiro, et al.
Publicado: (2022)

The Role of VP1 Amino Acid Residue 145 of Enterovirus 71 in Viral Fitness and Pathogenesis in a Cynomolgus Monkey Model
por: Kataoka, Chikako, et al.
Publicado: (2015)

Intramuscular Priming and Intranasal Boosting Induce Strong Genital Immunity Through Secretory IgA in Minipigs Infected with Chlamydia trachomatis
por: Lorenzen, Emma, et al.
Publicado: (2015)

Subacute SARS-CoV-2 replication can be controlled in the absence of CD8+ T cells in cynomolgus macaques
por: Nomura, Takushi, et al.
Publicado: (2021)

The Deubiquitinase OTUD1 Suppresses Secretory Neutrophil Polarization And Ameliorates Immunopathology of Periodontitis
por: Song, Jia, et al.
Publicado: (2023)

Apple-shaped obesity: A risky soil for cytokine-accelerated severity in COVID-19
por: Hosoya, Tadashi, et al.
Publicado: (2023)

Secretory IgA: Designed for Anti-Microbial Defense
por: Brandtzaeg, Per
Publicado: (2013)

The Effects of Secretory IgA in the Mucosal Immune System
por: Li, Yue, et al.
Publicado: (2020)

Immunopathologic Role of Eosinophils in Eosinophilic Chronic Rhinosinusitis
por: Shin, Seung-Heon, et al.
Publicado: (2022)

Serum under-O-glycosylated IgA1 level is not correlated with glomerular IgA deposition based upon heterogeneity in the composition of immune complexes in IgA nephropathy
por: Satake, Kenji, et al.
Publicado: (2014)

Neuropathogenicity of Two Saffold Virus Type 3 Isolates in Mouse Models
por: Kotani, Osamu, et al.
Publicado: (2016)

Acute Respiratory Infection in Human Dipeptidyl Peptidase 4-Transgenic Mice Infected with Middle East Respiratory Syndrome Coronavirus
por: Iwata-Yoshikawa, Naoko, et al.
Publicado: (2019)

Secretory component as the receptor for polymeric IgA on rat hepatocytes
Publicado: (1979)

Identification of secretory component as an IgA receptor on rat hepatocytes
Publicado: (1979)

Multi-Faceted Functions of Secretory IgA at Mucosal Surfaces
por: Corthésy, Blaise
Publicado: (2013)

Cannot write session to /tmp/vufind_sessions/sess_42ncfuuhcosoc2826ski5g6kdc